19Nov/13

End-Stage Heart Failure Patients Benefit from Injection of Millions of … – Science Daily (press release)


Science Codex

End-Stage Heart Failure Patients Benefit from Injection of Millions of
Science Daily (press release)
18, 2013 — A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left
Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure4-traders (press release)
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With GlobeNewswire (press release)

all 19 news articles »

19Nov/13

TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure – Family Practice News Digital Network

TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure
Family Practice News Digital Network
DALLAS – Spironolactone did not hit a home run in the large international “treatment of preserved cardiac function heart failure with an aldosterone antagonist” (TOPCAT) trial, but it did knock out a solid single in the form of significantly reduced